Caribou Biosciences Stock Price on November 19, 2024
| CRBU Stock | USD 2.20 0.18 8.91% |
If you're considering investing in Caribou Stock, it is important to understand the factors that can impact its price. As of today, the current price of Caribou Biosciences stands at 2.20, as last reported on the 29th of November, with the highest price reaching 2.20 and the lowest price hitting 2.00 during the day. Caribou Biosciences appears to be slightly risky, given 3 months investment horizon. Caribou Biosciences secures Sharpe Ratio (or Efficiency) of 0.0585, which signifies that the company had a 0.0585% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Caribou Biosciences, which you can use to evaluate the volatility of the firm. Please makes use of Caribou Biosciences' Downside Deviation of 5.05, risk adjusted performance of 0.0313, and Mean Deviation of 3.65 to double-check if our risk estimates are consistent with your expectations.
Stock Based Compensation is likely to gain to about 14.4 M in 2024, whereas Total Stockholder Equity is likely to drop slightly above 229 M in 2024. . Price Earnings To Growth Ratio is likely to gain to 0.27 in 2024, whereas Price To Sales Ratio is likely to drop 11.65 in 2024. Caribou Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Caribou |
Sharpe Ratio = 0.0585
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | CRBU | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 4.83 actual daily | 43 57% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.06 actual daily | 4 96% of assets perform better |
Based on monthly moving average Caribou Biosciences is performing at about 4% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Caribou Biosciences by adding it to a well-diversified portfolio.
Price Book 0.7084 | Enterprise Value Ebitda (36.94) | Price Sales 17.3609 | Shares Float 81.6 M | Wall Street Target Price 12.5 |
Related Headline
Intellia Therapeutics Headline on 19th of November 2024
Intellia Therapeutics price target lowered to 70 from 80 at ... by finance.yahoo.com
Wells Fargo lowered the firms price target on Intellia Therapeutics to 70 from 80 and keeps an Overweight rating on the shares. The firm notes that Phase 1 ATTR-CM data for nex-z compare well vs. historical data shown by silencers and stabilizers, despite having a greater proportion of patients with more severe disease. Wells thinks this should bode well for Phase 3 success. Published first on TheFly the ultimate source for real-time, market-moving breaking financial news. Try Now
Caribou Biosciences Valuation on November 19, 2024
It is possible to determine the worth of Caribou Biosciences on a given historical date. On November 19, 2024 Caribou was worth 1.97 at the beginning of the trading date compared to the closed value of 1.99. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Caribou Biosciences stock. Still, in general, we apply an absolute valuation method to find Caribou Biosciences' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Caribou Biosciences where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Caribou Biosciences' related companies.
| Open | High | Low | Close | Volume | |
| 1.99 | 2.09 | 1.93 | 1.98 | 1,397,225 | |
11/19/2024 | 1.97 | 2.02 | 1.91 | 1.99 | 1,254,330 |
| 2.00 | 2.08 | 1.91 | 1.96 | 2,230,085 |
| Backtest Caribou Biosciences | | | Caribou Biosciences History | | | Caribou Biosciences Valuation | Previous | Next |
Caribou Biosciences Trading Date Momentum on November 19, 2024
| On November 20 2024 Caribou Biosciences was traded for 1.96 at the closing time. The top price for the day was 2.08 and the lowest listed price was 1.91 . The trading volume for the day was 2.2 M. The trading history from November 20, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 1.51% . The overall trading delta against the current closing price is 2.51% . |
Caribou Biosciences Fundamentals Correlations and Trends
By evaluating Caribou Biosciences' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Caribou Biosciences' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Caribou financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Caribou Biosciences Stock history
Caribou Biosciences investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Caribou is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Caribou Biosciences will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Caribou Biosciences stock prices may prove useful in developing a viable investing in Caribou Biosciences
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 73.8 M | 69.3 M | |
| Net Loss | -89.5 M | -94 M |
Caribou Biosciences Quarterly Net Working Capital |
|
Caribou Biosciences Stock Technical Analysis
Caribou Biosciences technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Caribou Biosciences Period Price Range
Low | November 29, 2024
| High |
0.00 | 0.00 |
Caribou Biosciences cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Caribou Biosciences November 29, 2024 Market Strength
Market strength indicators help investors to evaluate how Caribou Biosciences stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Caribou Biosciences shares will generate the highest return on investment. By undertsting and applying Caribou Biosciences stock market strength indicators, traders can identify Caribou Biosciences entry and exit signals to maximize returns
Caribou Biosciences Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Caribou Biosciences' price direction in advance. Along with the technical and fundamental analysis of Caribou Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Caribou to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0313 | |||
| Jensen Alpha | (0.20) | |||
| Total Risk Alpha | (0.60) | |||
| Sortino Ratio | 0.0039 | |||
| Treynor Ratio | 0.0462 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Additional Tools for Caribou Stock Analysis
When running Caribou Biosciences' price analysis, check to measure Caribou Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Caribou Biosciences is operating at the current time. Most of Caribou Biosciences' value examination focuses on studying past and present price action to predict the probability of Caribou Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Caribou Biosciences' price. Additionally, you may evaluate how the addition of Caribou Biosciences to your portfolios can decrease your overall portfolio volatility.